2013
DOI: 10.1371/journal.pone.0057466
|View full text |Cite
|
Sign up to set email alerts
|

Caveolin-1 Regulates Endothelial Adhesion of Lung Cancer Cells via Reactive Oxygen Species-Dependent Mechanism

Abstract: The knowledge regarding the role of caveolin-1 (Cav-1) protein on endothelium adhesion of cancer cells is unclear. The present study revealed that Cav-1 plays a negative regulatory role on cancer-endothelium interaction. Endogenous Cav-1 was shown to down-regulate during cell detachment and the level of such a protein was conversely associated with tumor-endothelial adhesion. Furthermore, the ectopic overexpression of Cav-1 attenuated the ability of the cancer cells to adhere to endothelium while shRNA-mediate… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

4
13
0

Year Published

2014
2014
2020
2020

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 29 publications
(17 citation statements)
references
References 28 publications
4
13
0
Order By: Relevance
“…Multiple independent studies have indicated that CAV1 has a tumor-suppressor role in lung cancer and other types of malignancy (22,23,(31)(32)(33), which is consistent with the current findings, which revealed that the expression of CAV1 was significantly attenuated in lung cancer patients compared with healthy individuals. With regard to the mechanism, studies have demonstrated that CAV1 suppresses vascular cell adhesion protein 1-mediated adhesion between human lung cancer cells and endothelial cells by attenuating the production of hydrogen peroxide and hydroxyl radicals (32). In addition, CAV1 interacts with the StAR-related lipid transfer domain of deleted in liver cancer 1, another tumor suppressor that is frequently mutated in non-small cell lung cancer patients, and forms a complex to inhibit cancer cell migration and neoplastic development (31).…”
Section: Discussionsupporting
confidence: 92%
“…Multiple independent studies have indicated that CAV1 has a tumor-suppressor role in lung cancer and other types of malignancy (22,23,(31)(32)(33), which is consistent with the current findings, which revealed that the expression of CAV1 was significantly attenuated in lung cancer patients compared with healthy individuals. With regard to the mechanism, studies have demonstrated that CAV1 suppresses vascular cell adhesion protein 1-mediated adhesion between human lung cancer cells and endothelial cells by attenuating the production of hydrogen peroxide and hydroxyl radicals (32). In addition, CAV1 interacts with the StAR-related lipid transfer domain of deleted in liver cancer 1, another tumor suppressor that is frequently mutated in non-small cell lung cancer patients, and forms a complex to inhibit cancer cell migration and neoplastic development (31).…”
Section: Discussionsupporting
confidence: 92%
“…Shiroto et al showed that mitochondrial ROS production was increased in endothelial cells after cav-1 knockdown, and their results established that cav-1 plays a key role in regulating oxidative stress in the endothelium and may represent a critical target in cardiovascular diseases [40] . Chanvorachote and Chunhacha showed that cav-1 regulates the endothelial adhesion of lung cancer cells via a ROS-dependent mechanism [41] . Phosphorylation of cav-1 at tyrosine 14 was first identified in v-Src-transformed cells and facilitated the cav-1 interaction with other proteins in a stimulus-specific fashion [17] .…”
Section: Discussionmentioning
confidence: 99%
“…Others identified further potential target molecules responsible for an upregulation of VCAM‐1 contributing to cancer metastasis e.g . heparanase, caveolin, and IL‐8 . A downregulation approach for VCAM‐1 expressed by TCs or LEC is currently not available.…”
Section: Structural and Functional Aspects Of Vcam‐1 Biologymentioning
confidence: 99%
“…heparanase, caveolin, and IL-8. 105,161,162 A downregulation approach for VCAM-1 expressed by TCs or LEC is currently not available.…”
Section: Vcam-1 As Biomarker and As Potential Therapeutic Targetmentioning
confidence: 99%